Navigation Links
I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, Process
Date:5/24/2012

LAKE FOREST, Ill., May 24, 2012 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today released a snapshot of the positive impact of I.V. clinical integration of infusion pumps and electronic health records (EHRs) in honor of Healthcare Technology Management Week, which recognizes the important work of healthcare technology professionals.

(Photo: http://photos.prnewswire.com/prnh/20120524/CG13208-INFO)

(Logo: http://photos.prnewswire.com/prnh/20040503/HSPLOGO)

"The I.V. clinical integration of infusion pumps with electronic health record systems has been shown to decrease the time it takes for nurses to start a new infusion by at least 27 percent,"[1] said Richard Nevin, vice president, Medication Management Systems, U.S., Hospira. "Using I.V. clinical integration to link a smart infusion pump with EHRs helps deliver the trifecta for hospitals: safety, efficiency and financial benefits."

The following multimedia assets provide additional information about how I.V. clinical integration can enhance patient safety, clinician workflow and cost prevention efforts:

  • Why I.V. Clinical Integration of Infusion Pumps is So Smart: This infographic illustrates the functionality and benefits of I.V. clinical integration with Hospira MedNet™ safety software, including visuals that reflect the number of steps that can be removed from the medication delivery process.
  • Symbiq™ Infusion Pump Overview Video: A quick look at Hospira's newly enhanced Symbiq device -- recently given the first general infusion pump clearance from the U.S. Food and Drug Administration (FDA) under the new 510(k) guidelines -- and the role it plays in I.V. clinical integration.
  • IVclinicalintegration.com: An online hub of visual resources, case studies and news about I.V. clinical integration.

Using I.V. clinical integration to integrate medication management technologies with EHRs enables seamless, near real-time sharing of patient and infusion information between the hospital's clinical information systems, medication pumps and other devices. Intravenous or I.V. medication administration is crucial to the health of patients, as 90 percent of hospital patients receive an infusion as part of their treatments, and 56 percent of all medication errors are associated with I.V. medications.[2],[3] Improving the process through clinical integration can help clinicians positively impact their patients' overall health and safety.

About Hospira

Hospira, Inc. is the world's leading provider of injectable drugs and infusion technologies. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill., and has approximately 15,000 employees. Learn more at www.hospira.com.


[1] WellSpan Health. "WellSpan's collaborative efforts lead to Way-Paver," June 10, 2011, http://content.wellspan.org/breakingnews/default.aspx?pageID=11052, Accessed May 17, 2012.

[2] Hanchett, M. Visualizing the IV fluid path as an emerging concept in infection control. Infection Control Today. February 2004.

[3] Ross LM, Wallace J, Paton JY. Medication errors in a pediatric teaching hospital in the UK: five years operational experience. Arch Dis Child. 2000; 83(6);492-497

 


'/>"/>
SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... LAWRENCE, Mass. , Oct. 4, 2017 /PRNewswire/ ... developer of single-use, self-contained, illuminating medical devices, today ... National Health Surveillance Agency (or Agência Nacional ... ®. The first single-use, cordless surgical retractor with ... ONETRAC provides optimal access, illumination and exposure of ...
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
(Date:9/25/2017)... --  Montrium , an industry leader in powerful ... Trial Master Files & Inspection Readiness Conference ( ... Services has selected eTMF Connect to ... a leading European contract research organization (CRO), will ... enable greater collaboration with sponsors, improve compliance and ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to ... to save lost souls in the Philippines. “The Journey: From the Mountains to the ... teacher of the Bible. She has taught all ages and currently teaches a class ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... PALM CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... of cold therapy products, announced today the introduction of an innovative new design of ... the multipurpose pad so you get maximum comfort while controlling your pain while using ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
Breaking Medicine News(10 mins):